Biomedical Engineering Reference
In-Depth Information
195. Ashcroft, J. M.; Tsyboulski, D. A.; Hartman, K. B.; Zakharian, T. Y.; Marks, J. W.; Weisman,
R. B.; Rosenblum, M. G.; Wilson, L. J. Fullerene (C60) Immunoconjugates: Interaction of
Water-Soluble C60 Derivatives with the Murine Anti-gp240 Melanoma Antibody.
Chem.
Commun.
2006,
3004-3006.
196. Pusic, K.; Xu, H.; Stridiron, A.; Aguilar, Z.; Wang, A. Z.; Hui, H. Blood Stage Merozoite
Surface Protein Conjugated to Nanoparticles Induce Potent Parasite Inhibitory Antibodies.
Vaccine
2011,
29,
8898-8908.
197. Aguilar, Z. P.; Xu, H.; Dixon, J. D.; Wang, A. W.
Nanomaterials for Enhanced Antibody
Production
; Small Business Innovations Research for the National Science Foundation,
2012 (Ocean NanoTech, unpublished report).
198. Tada, H.; Higuchi, H.; Wanatabe, T. M.; Ohuchi, N. In Vivo Real-Time Tracking of Single
Quantum Dots Conjugated with Monoclonal Anti-HER2 Antibody in Tumors of Mice.
Cancer
Res.
2007,
67,
1138-1144.
199. Lee, C. C.; Gillies, E. R.; Fox, M. E.; Guillaudeu, S. J.; Fréchet, J. M.; Dy, E. E.; Szoka, F. C.
A Single Dose of Doxorubicin-Functionalized Bow-Tie Dendrimer Cures Mice Bearing C-26
Colon Carcinomas.
Proc. Natl. Acad. Sci. U.S.A.
2006,
103,
16649-16654.
200. Czerniawska, A. Experimental Investigations on the Penetration of 198Au from Nasal Mucous
Membrane into Cerebrospinal Fluid.
Acta Otolaryngol.
1970,
70,
58-61.
201. Pardridge, W. M. Why Is the Global CNS Pharmaceutical Market So Underpenetrated?
Drug
Discov. Today
2002,
7,
5-7.
202. Juillerat-Jeanneret, L. The Targeted Delivery of Cancer Drugs across the Blood-Brain Barrier:
Chemical Modifications of Drugs or Drug Nanoparticles?
Drug Discov. Today
2008,
13,
1099-1106.
203. Persidsky, Y.; Ramirez, S.; Haorah, J.; Kanmogne, G. Blood-Brain Barrier: Structural Compo-
nents and Function under Physiologic and Pathologic Conditions.
J. Neuroimmune Pharma-
col.
2006,
1,
223-236.
204. Hawkins, B. T.; Davis, T. P. The Blood-Brain Barrier/Neurovascular Unit in Health and Dis-
ease.
Pharmacol. Rev.
2005,
57,
173-185.
205. Begley, D. J. Delivery of Therapeutic Agents to the Central Nervous System: The Problems
and the Possibilities.
Pharmacol. Ther.
2004,
104,
29-47.
206. Chen, Y.; Dalwadi, G.; Benson, H. A. E. Drug Delivery across the Blood-Brain Barrier.
Curr.
Drug Del.
2004,
1,
361-367.
207. Brightman, M. W.; Reese, T. S. Junctions between Intimately Apposed Cell Membranes in the
Vertebrate Brain.
J. Cell Biol.
1969,
40,
648-677.
208. Saunders, N.; Knott, G.; Dziegielewska, K. Barriers in the Immature Brain.
Neurobiology
2000,
20,
29-40.
209. Saunders, N.; Ek, C. J.; Habgood, M. D.; Dziegielewska, K. M. Barriers in the Brain:
A Renaissance?
Trends Neurosci.
2008,
31,
279-286.
210. Stewart, P. A. Endothelial Vesicles in the Blood-Brain Barrier: Are They Related to Perme-
ability?
Cell Mol. Neurobiol.
2000,
20,
149-163.
211. Decleves, X.; Amiel, A.; Delattre, J. -Y.; Scherrmann, J. -M. Role of ABC Transporters in the
Chemoresistance of Human Gliomas.
Curr. Cancer Drug Targets
2006,
6,
433-445.
212. Tiwari, S. B.; Amiji, M. M. A Review of Nanocarrier-Based CNS Delivery Systems.
Curr.
Drug Del.
2006,
3,
219-232.
213. Wohlfart, S.; Gelperina, S. E.; Kreuter, J. Transport of Drugs across the Blood-Brain Barrier
by Nanoparticles.
J. Contr. Release
2012
, 161(2), 264-273.
214. Jeffries, W. A.; Brandon, M. R.; Hunt, S. V.; Williams, A. F.; Gatter, K. C.; Mason, D. Y. Trans-
ferrin Receptor on Endothelium of Brain Capillaries.
Nature
1984,
312,
162-163.
